Publicaciones en las que colabora con Enrique Navas Elorza (42)

2021

  1. COVID-19 and geographical area of origin

    Clinical Microbiology and Infection, Vol. 27, Núm. 4, pp. 632.e1-632.e5

2020

  1. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort

    The Lancet HIV, Vol. 7, Núm. 8, pp. e554-e564

2017

  1. Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253

2015

  1. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784

2014

  1. Extra-pulmonary tuberculosis: Differential aspects and role of 16S-rRNA in urine

    International Journal of Tuberculosis and Lung Disease, Vol. 18, Núm. 4, pp. 478-485

2013

  1. Infective endocarditis in congenital heart disease: A frequent community-acquired complication

    Infection, Vol. 41, Núm. 1, pp. 167-174

2011

  1. Changes in the epidemiology of tuberculosis: The influence of international migration flows

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 9, pp. 654-659

2010

  1. Infección por "mycobacterium tuberculosis"

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 10, Núm. 56, pp. 3808-3819

  2. Mycobacterium tuberculosis infection

    Medicine, Vol. 10, Núm. 56, pp. 3808-3819

2007

  1. Epidemiology and clinical features of tuberculosis in immigrants at an infectious diseases department in Madrid

    International Journal of Tuberculosis and Lung Disease, Vol. 11, Núm. 7, pp. 769-774

  2. Sputum conversion among patients with pulmonary tuberculosis: Are there implications for removal of respiratory isolation?

    Journal of Antimicrobial Chemotherapy, Vol. 59, Núm. 4, pp. 794-798

  3. Trends in neurological complications of endocarditis

    Journal of Neurology, Vol. 254, Núm. 9, pp. 1253-1259

2005

  1. Analysis of mortality and risk factors associated with native valve endocarditis in drug users: The importance of vegetation size

    American Heart Journal, Vol. 150, Núm. 5, pp. 1099-1106

  2. Linezolid for the treatment of multidrug-resistant tuberculosis

    Journal of Antimicrobial Chemotherapy, Vol. 56, Núm. 1, pp. 180-185

  3. Nosocomial endocarditis in a tertiary hospital: An increasing trend in native valve cases

    Chest, Vol. 128, Núm. 2, pp. 772-779

2003

  1. Nocardial infection in patients infected with the human immunodeficiency virus

    Clinical Microbiology and Infection, Vol. 9, Núm. 7, pp. 716-720

2002

  1. Clinical study of 44 cases of Staphylococcus aureus meningitis

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 21, Núm. 12, pp. 864-868

  2. Infection with Nocardia species: Clinical spectrum of disease and species distribution in Madrid, Spain, 1978-2001

    Infection, Vol. 30, Núm. 6, pp. 338-340

  3. Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy

    Archives of Internal Medicine, Vol. 162, Núm. 1, pp. 97-99

  4. Prophylaxis with oral fluconazole and an oral solution of amphotericin B in liver transplant patients

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 80-81